{
    "Trade/Device Name(s)": [
        "Calcium Gen. 2",
        "CA2",
        "Calcium Generation 2 Assay"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K113521",
    "Predicate Device Reference 510(k) Number(s)": [
        "K921661"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CHW"
    ],
    "Summary Letter Date": "March 30, 2012",
    "Summary Letter Received Date": "April 2, 2012",
    "Submission Date": "November 28, 2011",
    "Regulation Number(s)": [
        "21CFR862.1145"
    ],
    "Regulation Name(s)": [
        "Calcium Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Calcium"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma",
        "Urine"
    ],
    "Specimen Container(s)": [
        "Heparin tube",
        "Lithium heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Roche/Hitachi cobas c systems",
        "cobas c 501 analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Photometric test"
    ],
    "Methodologies": [
        "Photometric measurement"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Roche Calcium Gen. 2 photometric assay for quantitative measurement of calcium in serum, plasma, and urine",
    "Indications for Use Summary": "Quantitative determination of calcium in human serum, plasma, and urine for diagnosis and treatment of parathyroid disease, bone diseases, chronic renal disease, and tetany",
    "fda_folder": "Clinical Chemistry"
}